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Olanzapine and risperidone are widely prescribed atypical antipsychotics used in the treatment of 
schizophrenia and various other psychiatric disorders. Both of these drugs have been extensively 
reported to cause Type 2 diabetes mellitus and pancreatitis, however, the mechanism of olanzapine and 
risperidone‑induced toxicity has not been so far unveiled. We, therefore, compared the streptozocin‑
induced pancreatic damage with that of pancreas isolated from olanzapine and risperidone treated rats. 
It was noticed that fibrotic growth, necrosis and derangement of the pancreatic islet cells caused by 
streptozocin were more pronounced than olanzapine and risperidone.
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INTRODUCTION 
Olanzapine and risperidone are atypical antipsychotic 
drugs which are widely prescribed to treat schizophrenia 
and other psychotic illnesses. These drugs have also 
been reported to induce diabetes both in rats and humans 
(Shah et al., 2015; Weston‑Green, Huang, Deng, 2013). 
Several mechanisms of olanzapine‑ and risperidone‑
induced hyperglycemia and diabetes have been reported 
so far including their antagonistic effect on α1, α2, H1 and 
M3 receptors (Shah et al., 2015; Weston‑Green, Huang, 
Deng, 2013). It has been reported that antagonism of 
H1 receptors is associated with weight gain while M3 
receptors’ antagonism with pancreatic damage which leads 
to insulin insufficiency. Weston-Green and co-workers 
have shown in their review article that acetylcholine 
muscarinic receptors (M3) on the pancreas are one of the 
reasons that lead to insulin dysregulation (Weston‑Green, 
Huang, Deng, 2013). Studies have also shown that M3 
receptors antagonism is a risk for diabetes (Duttaroy et 
al., 2004; Weston‑Green et al., 2013). The M3 receptors 
located on pancreas are involved in regulating the glucose‑
stimulated cholinergic pathway of insulin release from the 
beta cells of the islet of Langerhans. These receptors, when 
stimulated, results in the release of insulin (Duttaroy et al., 
2004; Weston‑Green, Huang, Deng, 2013). Olanzapine 
and risperidone have been shown to block the M3 receptors 
on pancreas that decreases the insulin release (Weston‑
Green, Huang, Deng, 2013). However, such studies are 
still lacking that report the direct effect of olanzapine and 
risperidone on the architecture of pancreas of rats. We, 
therefore, designed this study to explore whether these 
drugs have any impact on the pancreatic histology by 
comparing it with the streptozocin‑induced pancreatic 
damage.
METHODS AND MATERIAL 
Sprague‑Dawley rats were bred in the Animal House 
and Bioassay Laboratory of the Department of Pharmacy, 
University of Peshawar. During experimental period, the 
rats were constantly observed and handled carefully in 
accordance with the rules specified under the Animals 
(Scientific Procedure) Act, 1986, UK and as approved by 
the Departmental Ethical Committee.
The rats had a free access to water whereas they 
were provided hygienic, palatable, dried and nutritional 
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food in restricted amount (20 g/12 h). Fresh water was 
frequently filled in bottles during day-time, and before the 
start of dark-cycle. The flow of water to the feeding tube 
was regularly checked. 
The sawdust was used as a bedding material in 
sufficient amount to avoid infection and to maintain the 
softness, dryness and hygiene of the surface. The bedding 
material was changed on daily basis or when required.
Procedures 
Drug treatment
The animals were kept fasted for 24 hours before 
first dose was administered. Olanzapine was formulated by 
dissolving it in small quantity of 0.1 N acetic acid followed 
by volume make‑up with normal saline in a 1:100 (Pouzet 
et al., 2003). Olanzapine was used once in daily doses of 
5 mg/kg/d (Pouzet et al., 2003) for first 8 weeks, 10 mg/
kg/d for next 4 weeks (Andersen, Pouzet, 2001; Pouzet et 
al., 2003) and 15 mg/kg/d for last 2 weeks (Angelucci et 
al., 2005) during the fourteen weeks experiment. Controls 
were administered with normal saline in a volume based 
on body weight (not greater than 5 ml/kg/d) (Pouzet et 
al., 2003). Both olanzapine and saline freshly prepared 
were administered on daily basis by oral gavage method 
during the same period (Pouzet et al., 2003; Shah et al., 
2015; Terry et al., 2003). The experiment continued for 
fourteen weeks.
Risperidone was used orally in a dose of 2.5 mg/kg/d 
for three weeks (Terry et al., 2003). It was formulated by 
dissolving in small quantity of 0.1 N acetic acid followed 
by volume make‑up with normal saline in a ratio of 1 
to 100. Normal saline as a control was administered in 
a volume based on body weight (not greater than 5ml/
kg/d). Drug containing solution and normal saline were 
administered by oral gavage method. Fresh solution of 
drug was prepared each day and the experiment continued 
for three weeks.
Streptozocin was administered at a dose of 50 mg/
kg/ip for diabetes induction. The samples of pancreas of 
rats treated with streptozocin were obtained from rats with 
confirmed diabetes (Ali et al., 2015). 
Histological study
The animals were sacrificed by cervical dislocation, 
selected tissues were isolated and washed with phosphate 
buffered saline (PBS) and fixed in neutral buffered 
formalin (NBF) for not less than 6 hours. The fixed 
samples of tissues were sliced into small pieces of 3–5 mm 
and embedded separately in paraffin blocks. These blocks 
were sectioned using microtome (SLEE MAINZ, CUT 
5062). Sections of 5 µ size were taken and stained using H 
& E staining technique (Ali et al., 2015; Shah et al., 2015).
Microscopy
The stained slides were analyzed under a light 
microscope (LABOMED LX400, USA) equipped with 
camera (iVu 3100). The images obtained were labeled, 
saved and interpreted for any drug induced changes.
RESULTS 
Normal saline
The pancreas of saline treated rats showed normal 
architecture of the Islet of Langerhans with compact 
arrangement of beta and non beta cells. The islet appeared 
lightly stained than the surrounding acinar cells, and 
consisted of slightly stained polygonal cells arranged in 
cords separated by a network of blood capillaries. The 
acinar cells were characterized by its basal basophilia 
and apical acidophilia, as depicted in Figures 1A and 1B.
Olanzapine 
As shown in Figure 1C and 1D, olanzapine was 
associated with reduction in the number of beta cells. 
The islets were irregularly shaped having a lobular 
appearance along with increase in fibrotic growth. The 
beta cells showed extensive necrosis, degeneration and 
vacuolization with eosinophilic cytoplasm. Most of the 
nuclei exhibited karyolysis and pyknosis while others 
were darkly stained with chromatin condensation along the 
periphery. The blood vessels of the islets showed dilatation 
and were heavily congested with red blood cells.
Risperidone
The islets of Langerhans in the pancreas of 
risperidone treated rats seemed scattered showing 
derangement of pancreatic islets cells. The cells lost their 
arrangement in cords and compaction contrary to the 
architecture observed in normal saline treated pancreas, 
showing lobular appearance and fibrotic growth in the 
similar fashion as seen in olanzapine treated rats, depicted 
in Figures 1E and 1F.
Streptozocin 
As depicted in Figure 1G and 1H, streptozocin 
seemed extremely toxic to the pancreatic cells thereby 
rendering severe damage to the beta cells. The islet cells 
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FIGURE 1 - (A-D): Effect of normal saline and olanzapine on the pancreas of rats (H & E, 100x, 400x, 5μ): Representative image 
of pancreas of rats treated with normal saline (A & B) orally for three weeks showing islets of Langerhans, packed as compact and 
intact glandular mass. Photomicrographs of a section (5 μm) of pancreas from a rat treated with olanzapine (C & D) (5 mg/kg/d for 
the first eight weeks, 10 mg/kg/d in next four weeks and 15 mg/kg/d in the last two weeks), showing nodular appearance of islet 
of Langerhans due to fibrotic growth with derangement of beta cells. Effect of risperidone on the pancreas of rats (H & E, 100x, 
400x,5 μ) (E-F): Representative images of pancreas of rats treated with risperidone (2.5 mg/kg/d) orally for three weeks showing 
derangement of islets of Langerhans, lacking compaction of glandular cells as compared to rats treated with normal saline (A & B). 
Effect of streptozocin on the pancreas of rats (H & E, 100x, 400x,5 μ): Representative images of pancreas of rats treated with 
streptozocin (G ‑H) (50 mg/kg/d/ip) showing derangement of islets of Langerhans, lacking compaction of glandular cells as 
compared to rats treated with normal saline.
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were shown dispersed, irregular and necrosed. The beta 
cells exhibited extensive necrosis, degeneration, fibrosis 
and vacuolization. Paucity of islet cells was observed in 
streptozocin treated pancreas.
DISCUSSION 
We compared the histopathology of streptozocin 
treated pancreas of rats with normal saline, olanzapine and 
risperidone treated pancreas. We noticed derangement of 
islet cells in olanzapine and risperidone treated rats, while 
fibrotic growth in olanzapine and streptozocin treated rats, 
however the streptozocin‑induced pancreatic damage was 
more pronounced (Shah et al., 2015; Ali et al., 2015).
It is believed that the diabetogenic effect of 
streptozocin, is due to oxidative stress, since increased 
reactive oxygen species have been observed in pancreatic 
tissues (Coskun et al., 2005; Ihara et al., 1999). It has 
been shown that streptozocin depletes the intracellular 
nicotinamide dinucleotide (NAD) in islet cells (Coskun et 
al., 2005; Schein et al., 1973). Furthermore, it has also been 
proved that streptozocin causes the breakdown of DNA 
strands that results in methylation within the pancreatic 
islet cells, which in turn, leads to pancreatic damage 
(Coskun et al., 2005; Matkovics et al., 1996). Persistent 
and chronic hyperglycemia leads to oxidative stress that in 
turn causes the depletion of antioxidative defense system 
thereby leading to generation of free radicals (Coskun 
et al., 2005; Ihara et al., 1999). Streptozocin‑induced 
diabetes has also been shown histopathologically (Ali et 
al., 2015; Coskun et al., 2005; Das, Padayatti, Pauiose, 
1996) wherein fibrotic growth and derangement of islet 
cells have been described.
Although, risperidone treatment did not induce 
hyperglycemia, but pancreatic damage and pancreatitis 
were depicted by elevated amylase levels. Similarly, 
olanzapine showed weight loss, hyperglycemia, 
hyperamylasemia, hyperlipasemia, derangement of beta 
cells and fibrotic growth as reported by our laboratory 
(Shah et al., 2015). 
Studies have shown that M3 receptor antagonism 
results in insulin insufficiency which might be attributed 
to ultimate damage. It may, however, be assumed that 
olanzapine and risperidone might be involved in the 
generation of free radicals at the level of pancreas, in 
the same pattern, but with low intensity as streptozocin 
(Weston‑Green, Huang, Deng, 2013). 
There are very limited data available that describe 
the role of olanzapine and risperidone in causing oxidative 
stress and generation of free radicals, which are also 
contradictory, in the sense that typical antipsychotic 
(Haloperidol) causes oxidative stress but atypical 
antipsychotic drugs do not (Ng et al., 2008). On the other 
hand, risperidone has been reported to be associated with 
oxidative stress (Ng et al., 2008; Pillai et al., 2007) while 
olanzapine plays a protective role against the oxidative 
stress in schizophrenic patients (Pillai et al., 2007). The 
data which show oxidative stress in animals or humans 
employing pancreas specific markers are still needed to 
be evaluated.
In our study, antipsychotics‑induced pancreatic 
damage is a step forward towards exploration of 
mechanistic pathway, wherein oxidative stress could be 
the major cause of pancreatic damage in olanzapine‑ 
and risperidone‑treated rats, in the same pattern as 
streptozocin.
CONCLUSION 
Olanzapine and risperidone caused fibrotic 
growth, necrosis and derangement of the islet cells of 
pancreas, which was more pronounced in rats treated with 
streptozocin as compared to treatment with olanzapine 
and risperidone.
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